# ELENAE THERAPEUTICS INC: Antisense oligonucleotide targeting a pathological microRNA for heart failure treatment

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ELENAE THERAPEUTICS INC |
| Location | BERKELEY, CA |
| Project | Antisense oligonucleotide targeting a pathological microRNA for heart failure treatment |
| Project number | 1R44HL184643-01A1 |
| Mechanism | R44 |
| Institute | National Heart Lung and Blood Institute |
| Award | $706,528 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-18 to 2028-06-30 |
| UEI | NBD7WR3CNHH9 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409761). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.